Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

CA209-817: A Phase IIIb/IV Safety Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Arizona Oncology - Chandler

A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

312 N. Alma School Rd., Suite 14
Chandler, AZ 85224
P: (480) 256-1689

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Tucson

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, AZ 85704
P: (520) 531-8967

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Tucson

(UTX-TGR-304) Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with TGR-1202 Compared to Obinutuzumab in Combination with Chlorambucil in Patients with Chronic Lymphocytic Leukemia (CLL)

  • Details

ClinicalTrials.gov ID: NCT02612311
Diagnosis Type: CLL
USOR Number: 15229

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, AZ 85704
P: (520) 531-8967

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase III Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple Negative Breast Cancer (TNBC) MK-3475-522

  • Details

ClinicalTrials.gov ID: NCT03036488
Diagnosis Type: NA
USOR Number: 16208

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Phoenix

A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy (ACE-CL-208)

  • Details

ClinicalTrials.gov ID: NCT02717611
Diagnosis Type: CLL
USOR Number: 15222

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinoma (MK-3475-361)

  • Details

ClinicalTrials.gov ID: NCT02853305
Diagnosis Type: NA
USOR Number: 16054

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Tucson

(UTX-TGR-204) A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

  • Details

ClinicalTrials.gov ID: NCT02656303
Diagnosis Type: CLL
USOR Number: 16213

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Glendale

Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma (HER2CLIMB) (ONT-380-206)

  • Details

ClinicalTrials.gov ID: NCT02614794
Diagnosis Type: NA
USOR Number: 16195

  • Practice Details

7200 W Bell Road, Building A
Glendale, AZ 85308
P: (623) 487-4822

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, AZ 85027
P: (602) 357-2400

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Tucson

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Tucson

(UTX-TGR-304) Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with TGR-1202 Compared to Obinutuzumab in Combination with Chlorambucil in Patients with Chronic Lymphocytic Leukemia (CLL)

  • Details

ClinicalTrials.gov ID: NCT02612311
Diagnosis Type: CLL
USOR Number: 15229

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase III Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple Negative Breast Cancer (TNBC) MK-3475-522

  • Details

ClinicalTrials.gov ID: NCT03036488
Diagnosis Type: NA
USOR Number: 16208

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Scottsdale

A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy (ACE-CL-208)

  • Details

ClinicalTrials.gov ID: NCT02717611
Diagnosis Type: CLL
USOR Number: 15222

  • Practice Details

10460 N 92nd St, Suite 402
Scottsdale, AZ 85258
P: (480) 860-2540

More Details View Practice Page

Myelomas

Clinical Trial at: Arizona Oncology - Phoenix

Daratumumab plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated and Relapsed Subjects with Multiple Myeloma (54767414MMY2012)

  • Details

ClinicalTrials.gov ID: NCT02951819
Diagnosis Type: NA
USOR Number: 16084

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Leukemia

Clinical Trial at: Arizona Oncology - Tucson

(UTX-TGR-204) A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

  • Details

ClinicalTrials.gov ID: NCT02656303
Diagnosis Type: CLL
USOR Number: 16213

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

10460 N 92nd St, Suite 402
Scottsdale, AZ 85258
P: (480) 860-2540

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma (HER2CLIMB) (ONT-380-206)

  • Details

ClinicalTrials.gov ID: NCT02614794
Diagnosis Type: NA
USOR Number: 16195

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, AZ 85016
P: (602) 277-4868

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

PR-30-5017-C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response On Front-Line Platinum-Based Chemotherapy (PRIMA)

  • Details

ClinicalTrials.gov ID: NCT02655016
Diagnosis Type: NA
USOR Number: 16211

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, AZ 85704
P: (520) 531-8967

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Tucson

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Pages